67,95 €
67,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
34 °P sammeln
67,95 €
67,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
34 °P sammeln
Als Download kaufen
67,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
34 °P sammeln
Jetzt verschenken
67,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
34 °P sammeln
  • Format: ePub

Transform your research into commercial biomedical products with this revised and updated second edition. Covering drugs, devices and diagnostics, this book provides a step-by-step introduction to the process of commercialization, and will allow you to create a realistic business plan to develop your ideas into approved biomedical technologies. This new edition includes: Over 25% new material, including practical tips on startup creation from experienced entrepreneurs. Tools for starting, growing and managing a new venture, including business planning and commercial strategy, pitching…mehr

  • Geräte: eReader
  • mit Kopierschutz
  • eBook Hilfe
  • Größe: 11.08MB
  • FamilySharing(5)
Produktbeschreibung
Transform your research into commercial biomedical products with this revised and updated second edition. Covering drugs, devices and diagnostics, this book provides a step-by-step introduction to the process of commercialization, and will allow you to create a realistic business plan to develop your ideas into approved biomedical technologies. This new edition includes: Over 25% new material, including practical tips on startup creation from experienced entrepreneurs. Tools for starting, growing and managing a new venture, including business planning and commercial strategy, pitching investors, and managing operations. Global real-world case studies, including emerging technologies such as regulated medical software and Artificial Intelligence (AI), offer insights into key challenges and help illustrate complex points. Tips and operational tools from established industry insiders, suitable for graduate students and new biomedical entrepreneurs.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Shreefal S. Mehta is Clinical Associate Professor of Biotechnology Management and Biomedical Engineering, Rensselaer Polytechnic Institute and Vice President, Business and Corporate Development, Cytopia Inc. He received his PhD in Biomedical Engineering from University of Texas Southwestern Medical Center in 1995. He was CEO and co-founder of Myomatrix Therapeutics, a cardiovascular pharmaceutical startup and recipient of the '40 under 40' award for rising business leaders in New York. He has been a reviewer for the NSF Biotechnology Commercialization SBIR Review panel.